A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections

Clicks: 218
ID: 6326
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1,506 of 1,693 articles by views in Infection and drug resistance

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,693 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections Aditya K Gupta,1,2 Deanne Daigle2 1Department of Medicine, University of Toronto School of Medicine, Toronto, 2Dermatology, Mediprobe Research Inc., London, ON, Canada Abstract: Luliconazole is a novel imidazole derivative, which has demonstrated in vitro efficacy against dermatophytes and Candida. The results from Phase III trials show that luliconazole 1% cream applied once daily for 2 weeks successfully resolved the clinical signs and symptoms as well as eradicated the pathologic fungi, which cause tinea pedis. A 1-week treatment with luliconazole 1% cream also produced favorable clinical and mycological results in clinical trials for tinea corporis and tinea cruris. Across trials, adverse events consisted mainly of localized reactions following application. The development of a new antifungal agent is timely due to mounting resistance among existing treatments. Because luliconazole requires a short duration of treatment, it may assist in reducing disease recurrence as a result of patient nonadherence. Keywords: antifungal, dermatophyte, athlete's foot, tinea cruris, tinea corporis, imidazole
Reference Key
aditya2016ainfection Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Aditya K Gupta;Deanne Daigle and
Journal Infection and drug resistance
Year 2016
DOI
10.2147/IDR.S61998
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.